Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001555280-25-000274
Filing Date
2025-11-04
Accepted
2025-11-04 15:02:59
Documents
94
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zts-20250930.htm   iXBRL 10-Q 2335864
2 EX-10.2 rpletteragreement_102925ex.htm EX-10.2 109560
3 EX-31.1 a10qex311q32025.htm EX-31.1 8846
4 EX-31.2 a10qex312q32025.htm EX-31.2 8956
5 EX-32.1 a10qex321q32025.htm EX-32.1 4116
6 EX-32.2 a10qex322q32025.htm EX-32.2 4091
12 GRAPHIC image_0.jpg GRAPHIC 36550
13 GRAPHIC image_1.jpg GRAPHIC 7088
  Complete submission text file 0001555280-25-000274.txt   10771808

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20250930.xsd EX-101.SCH 55659
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT zts-20250930_cal.xml EX-101.CAL 81301
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT zts-20250930_def.xml EX-101.DEF 312374
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20250930_lab.xml EX-101.LAB 720233
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20250930_pre.xml EX-101.PRE 545911
97 EXTRACTED XBRL INSTANCE DOCUMENT zts-20250930_htm.xml XML 1838041
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35797 | Film No.: 251448366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)